Chemical Pathology Of Homocysteine. V. Thioretinamide, Thioretinaco, And Cystathionine Synthase Function In Degenerative Diseases

This research investigates homocysteine, an amino acid that becomes harmful when levels are too high in the blood. Scientists first noticed that children born with genetic disorders affecting homocysteine metabolism developed severe heart disease at young ages. This observation led to decades of research into how elevated homocysteine contributes to various degenerative diseases.

The study focuses on how homocysteine disrupts normal cellular processes. When homocysteine levels are elevated, it interferes with the body's ability to produce energy efficiently at the cellular level. Specifically, it affects a process called oxidative phosphorylation, which is how cells normally create energy. The research suggests that cancer cells may actually be selected for their inability to properly process homocysteine, forcing them to rely on a less efficient energy production method called glycolysis.

The research also explores how elevated homocysteine contributes to atherosclerosis (hardening of the arteries). According to this work, homocysteine modifies proteins and lipids in ways that make them more likely to form dangerous plaques in blood vessels. These modified substances can combine with microbes to create blockages that lead to heart attacks and strokes.

The findings suggest that certain nutrients, particularly vitamin C and B vitamins, play crucial roles in keeping homocysteine levels in check. This research reinforces the clinical importance of measuring homocysteine levels and ensuring adequate B-vitamin status as part of comprehensive metabolic health assessment and cardiovascular disease prevention.